Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1233

1.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

2.

RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.

Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY.

PLoS One. 2014 Sep 30;9(9):e108507. doi: 10.1371/journal.pone.0108507. eCollection 2014.

3.

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.

Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.

J Exp Clin Cancer Res. 2009 Feb 26;28:28. doi: 10.1186/1756-9966-28-28.

4.
5.
6.

Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.

Kim MR, Choi HK, Cho KB, Kim HS, Kang KW.

Cancer Sci. 2009 Oct;100(10):1834-41. doi: 10.1111/j.1349-7006.2009.01260.x. Epub 2009 Jul 24.

7.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

8.

HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells.

Kim J, Jeong H, Lee Y, Kim C, Kim H, Kim A.

BMC Cancer. 2013 Aug 12;13:383. doi: 10.1186/1471-2407-13-383.

9.

RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.

Palafox M, Ferrer I, Pellegrini P, Vila S, Hernandez-Ortega S, Urruticoechea A, Climent F, Soler MT, Muñoz P, Viñals F, Tometsko M, Branstetter D, Dougall WC, González-Suárez E.

Cancer Res. 2012 Jun 1;72(11):2879-88. doi: 10.1158/0008-5472.CAN-12-0044. Epub 2012 Apr 10.

10.

Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.

Li NY, Weber CE, Mi Z, Wai PY, Cuevas BD, Kuo PC.

J Am Coll Surg. 2013 Jul;217(1):17-26; discussion 26. doi: 10.1016/j.jamcollsurg.2013.02.025. Epub 2013 Apr 23. Erratum in: J Am Coll Surg. 2015 Aug;221(2):642.

PMID:
23619316
11.

Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.

Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH.

J Mol Med (Berl). 2014 Jan;92(1):53-64. doi: 10.1007/s00109-013-1083-4. Epub 2013 Sep 5.

PMID:
24005829
12.

CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.

Biswas S, Sengupta S, Roy Chowdhury S, Jana S, Mandal G, Mandal PK, Saha N, Malhotra V, Gupta A, Kuprash DV, Bhattacharyya A.

Breast Cancer Res Treat. 2014 Jan;143(2):265-76. doi: 10.1007/s10549-013-2811-8. Epub 2013 Dec 13.

PMID:
24337540
14.

The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.

Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E.

Carcinogenesis. 2011 Nov;32(11):1634-40. doi: 10.1093/carcin/bgr198. Epub 2011 Sep 1.

15.
16.

Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.

Huang T, Chen Z, Fang L.

Oncol Rep. 2013 Jan;29(1):117-24. doi: 10.3892/or.2012.2080. Epub 2012 Oct 16.

PMID:
23076367
17.

CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.

Jin L, Chen J, Li L, Li C, Chen C, Li S.

Cell Signal. 2014 Apr;26(4):757-65. doi: 10.1016/j.cellsig.2013.12.017. Epub 2014 Jan 8.

PMID:
24412750
18.

Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.

Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, Chang WW.

Breast Cancer Res. 2011 Oct 24;13(5):R101. doi: 10.1186/bcr3042.

19.

Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.

Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaff AM, Wu TJ, Lin BR, Yang MH, Hortobagyi GN, Hung MC.

Cancer Res. 2012 Mar 1;72(5):1290-300. doi: 10.1158/0008-5472.CAN-11-3123. Epub 2012 Jan 17.

20.

Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.

Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW.

Cell Res. 2008 Aug;18(8):858-70. doi: 10.1038/cr.2008.84.

PMID:
18645583
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk